A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease is a research paper published in Clinical Kidney Journal (2022). On theSindex it has a DataRank of 2.0. It has been cited 102 times, with 91 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.695
From this paper's citation signal
Citation Network Contribution
1.3
From 63 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 91 citers.
Bayer AG
FWCI
10.28
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals